相关实验视频

Updated: May 23, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

刺激响应的聚合物-达沙替尼前药物用于重编程与癌症相关的纤维细胞,以促进免疫疗法

Yuxin Zhang¹, Jie Zhou¹, Yiyan Wang¹

¹Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Breast Center, Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

Journal of controlled release : official journal of the Controlled Release Society

|March 7, 2025

概括

这项研究开发了一种新型前药物CS-GFLG-DAS,用于在三阴性乳腺癌免疫治疗中克服与癌症相关的纤维细胞障碍. 这种方法增强了药物透和免疫细胞透,提高了抗PD-1疗法的疗效.

科学领域:

在瘤学瘤学.
纳米医学是一种纳米医学.
免疫治疗是一种免疫疗法.

背景情况:

与癌症相关的纤维细胞 (CAFs) 阻碍了三阴性乳腺癌 (TNBC) 的免疫治疗疗效.
CAFs造成障碍,包括药物透不良,有限的细胞毒性T淋巴细胞 (CTL) 透,以及免疫抑制瘤微环境.
针对CAF对于提高癌症治疗结果至关重要.

研究的目的:

为了设计一种前药物,即氏硫酸合达沙替尼 (CS-GFLG-DAS),以逆转CAF表型并增强免疫检查点阻塞 (ICB) 疗法.
研究前药物在调节细胞外基质 (ECM) 和促进药物透中的作用机制.
在TNBC小鼠模型中评估前药与抗PD-1疗法的协同效应.

主要方法:

达沙替尼 (DAS) 通过对甲素B (CTSB) 敏感的GFLG链接剂与氏丁硫酸盐 (CS) 结合,形成CS-GFLG-DAS (CGD).
在体外和体内研究评估CAF调节,ECM调节,药物透和CTL透.
用CGD和抗PD-1疗法治疗的4T1瘤携带小鼠治疗疗效的评估.

主要成果:

作为瘤微环境中CTSB升高的反应,CGD释放达沙替尼,将CAF转化为静止状态.
静态CAFs降低了ECM的产生,促进了CGD更深入的透,并增强了瘤细胞的杀死.
治疗CGD促进了CTL透,并协同增强了抗PD-1免疫疗法的疗效.
在组合治疗组中观察到显著的瘤生长抑制.

结论:

开发的前药物CGD有效调节CAF和ECM,增强药物透和免疫治疗敏感性.
这种纳米医学方法为克服纤维化瘤中CAF介导的耐药性提供了一个有希望的策略.
通过纳米医学调节瘤微环境为优化癌症免疫治疗提供了新的见解.

关键词:

反瘤免疫力抗瘤免疫力乳腺癌乳腺癌乳腺癌与癌症相关的纤维细胞.免疫检查站封锁免疫检查站封锁纳米医学是一种纳米医学.瘤的细胞外基质.

更多相关视频

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...